Every vendor in this category now claims autonomous. The question that actually separates them is what happens after the AI finds something: does it get exploited, validated by a human, and re-tested after the fix, or does it just get listed.
This is a comparison framework, not a feature dump. It is built around the five questions worth asking any vendor before you shortlist them, and it is written by a vendor in the category. Treat the criteria as the thing to interrogate, then go verify how each platform actually answers them.
The category got crowded before it got clear
Type autonomous pentesting platform into a search box and you now get an AI Overview, a handful of vendor homepages, and very little that helps you actually choose. Horizon3.ai, XBOW, Cobalt, BreachLock, and others all use the same three words, autonomous, continuous, AI-driven, to describe fairly different products.
As a CTO evaluating this category, you are not short on marketing claims. You are short on a framework to tell them apart. Every vendor says they run real attacks. Every vendor says they go beyond a ranked scan. Every vendor has a diagram with the words "hack, fix, verify, repeat" or some close variant of it.
That sameness is the problem. It means the differentiators that actually matter to your engineering org are buried under near-identical homepage copy: how deep the exploitation goes, who signs off on a finding before it reaches your team, whether a fix gets re-tested or just marked closed, and how fast the whole loop turns.
The five questions that actually separate these platforms
Most autonomous pentesting vendors will answer yes if you ask them broad questions like "do you validate exploitability?" or "is this continuous?" The useful questions are more specific.
1. What gets exploited, and what just gets flagged? Some platforms run automated attack chains end to end and hand you a working exploit. Others run reconnaissance and vulnerability correlation, then flag findings that look exploitable without actually proving it. Ask a vendor directly: for a critical finding, what is in the report, a CVSS score and a description, or a reproducible proof of concept with the replay steps?
2. Where does a human sign off, and what do they actually check? AI-driven and unattended are not the same thing, and the industry is not consistent about which one it is selling. Some platforms run fully automated with no review layer before findings reach you. Others put a named human in the loop who reviews the execution plan, validates the finding, and stands behind the report. Ask what the human actually reviews: the whole attack chain, or just a final summary.
3. Is retest included, or is it a separate line item? A fix that has not been re-tested against the live environment is a closed ticket, not a closed risk. Some platforms treat verification as a built-in step in the loop. Others treat it as a new engagement, with new scoping and a new invoice. This is one of the more consequential differences in total cost and in whether you actually know your exposure went down.
4. How fast does a finding go from discovery to attested report? Continuous gets used loosely. Ask what continuous actually means end to end: does new attack surface enter testing automatically when it ships, or does the platform still run on a scheduled window that happens to be shorter than an annual pentest? Weeks, not months, is a meaningfully different claim from days, not hours, and vendors are not always precise about which one they are making.
5. What is the safety model against production? If a platform cannot be pointed at production without real risk of causing an outage, your riskiest environment stays the least tested. Ask what configurable safe-mode actually restricts, and whether scope and written authorization are locked down before anything executes.
Walking the loop: map, break, validate, prove
Strip away the branding and most credible autonomous pentesting platforms, XEUS included, run some version of the same four-stage loop. The differences show up in how each stage is executed, not whether it exists.
1. Map. The platform builds a model of the attack surface: external hosts, cloud resources, identities, and (for internal testing) the estate reached through an agent or tunnel. The question is whether this model is a point-in-time snapshot refreshed on a schedule, or a live model that updates as your environment changes.
2. Break. Against signed scope, the platform attempts real exploitation, not just correlation against a CVE database. This is where autonomous earns or loses its meaning. Chaining a handful of individually low-severity exposures into a path that reaches a production database is a materially different capability than flagging each exposure on its own.
3. Validate. A finding gets confirmed as genuinely exploitable, ideally with a human reviewing the chain and the evidence before it reaches you, not a scanner's confidence score.
4. Prove. The report carries a working proof of concept and reproduction steps your team can run themselves. When you ship a fix, the platform re-runs the original attack against the live surface to confirm the path is closed, and flags it again if a regression brings it back.
That fourth step is where most of the category quietly drops the ball. Plenty of platforms will happily run stage two and three at genuine scale. Fewer are built to close the loop back to your fix and prove it worked without opening a new engagement.
Old way vs. XEUS
| Legacy pentest / scanners | Autonomous platforms generally | XEUS | |
|---|---|---|---|
| Cadence | Annual or quarterly, booked window | Varies: some scheduled, some continuous | Continuous, not annual |
| Speed | Weeks to schedule, weeks to deliver | Faster, but delivery speed varies widely by vendor | Weeks, not months, against a live surface |
| Coverage | Fixed scope agreed months in advance | Broader, but depth of exploitation varies | Live attack surface model, updated as it changes |
| Attack chaining | Manual, tester-dependent | Ranges from real chaining to correlated flagging | Individually minor exposures chained into demonstrated attack paths |
| Evidence | Narrative findings, sometimes unvalidated | Ranges from CVSS-ranked lists to working PoCs | Working exploit and replay trace on every finding |
| Retest | Usually a separate, re-scoped engagement | Often a separate step or add-on | Included: the same path is re-run after the fix ships |
| Accountability | A named human tester, but slow | Ranges from fully unattended to human-reviewed | AI Executed - Human Validated, with a human standing behind the report |
The pattern worth noticing: the industry has mostly solved cadence and speed. Continuous, AI-driven testing is table stakes now. What is still uneven is chaining depth, evidence quality, and whether retest is a genuine loop-closer or a re-sold engagement.
Why demonstrated attack chains and included retest are the real differentiator
Two open findings can carry the same CVSS score and mean completely different things. One sits on a host with no path anywhere. The other chains with two other minor misconfigurations into full access to your customer database. A count of open findings cannot tell you which is which. Only a demonstrated attack path can.
This is the gap between a validated path and a ranked list, and it is the reason autonomous is not automatically better than a scanner. It is only better when the autonomy is spent on actually attempting exploitation and chaining, not on running the same correlation logic faster.
Retest closes the other half of the gap. A remediation ticket marked fixed is a claim. Re-running the original attack against the live environment and watching the path fail is proof. Without that step, a closed ticket and a closed attack path are two different things that happen to share a status label. With it, they mean the same thing, and if a regression reopens the path, that gets caught before an attacker finds it, not at the next scheduled engagement.
Where XEUS fits in this comparison
XEUS is built around the four stages above, deliberately: a live attack surface model across external, cloud, identity, and internal estate; real exploitation against signed scope rather than unvalidated scanning; a named human operator who reviews and stands behind every finding, AI Executed - Human Validated; and a retest that re-runs the original attack once a fix ships, so risk only drops when the path is actually gone.
That combination is the direct answer to the two pains that show up most often in conversations with engineering-led teams: security testing arriving on a cadence that cannot keep up with a continuous release cycle, and a pile of scan output with no way to tell which findings actually chain into impact.
XEUS does not run unattended. Scope and written authorization are agreed before anything executes, and configurable safe-mode governs behavior against production, because the environment that most needs testing is usually the one nobody wants to point automated tooling at unsupervised.
How to run your own comparison
When you get on a call with any vendor in this category, bring these questions instead of asking for a demo of the dashboard:
- Show me a finding end to end: the exploit chain, the proof of concept, and the reproduction steps.
- Walk me through what a human reviews before a finding reaches my team, and what happens if they disagree with the AI's output.
- What does retest actually involve: is it included, and does it re-run the original attack or just re-scan?
- What is your delivery time from a new exposure appearing to an attested finding?
- What specifically does your safe-mode restrict, and what is agreed in writing before testing starts?
The answers will tell you more than any comparison table, including this one. If you want them answered against your own estate, book a scoping call.
Questions we get asked
Is an autonomous pentesting platform the same as a vulnerability scanner?
No. A scanner correlates signatures and version data to flag possible issues without proving they are exploitable. An autonomous pentesting platform, done properly, actually attempts exploitation against signed scope and chains individually minor exposures into a demonstrated attack path. If a platform cannot show you a working proof of concept for a finding, it is functioning as a scanner regardless of what it is marketed as.
Does autonomous mean there is no human involved?
It should not. Autonomous describes how the testing executes, not who is accountable for the result. XEUS runs AI-executed testing with a named human operator who reviews and validates findings before they reach you: Human in the Loop, not an unattended tool making unsupervised claims about your environment.
Is it safe to run autonomous pentesting against production?
It depends entirely on the platform's safety controls. Configurable safe-mode, agreed scope, and written authorization before anything runs are what make production testing viable. Without those, production is rightly treated as too risky to test, which is exactly how it ends up being the least-tested, highest-risk environment in most organizations.
How is a finding validated before it reaches my team?
A finding should carry a working exploit and a replay trace your team can run themselves, reviewed by a human before delivery. If a finding cannot be reproduced, it is not validated. It is a ranked guess, and that is exactly what scan-based tools already produce in volume.
Is retest included or a separate engagement?
This varies by vendor and is worth asking about directly before you buy. With XEUS, retest is part of the loop: once a fix ships, the platform re-runs the original attack against the live surface to confirm the path is closed, and flags it again if it regresses.